This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Yale University. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: David Gimbel: Innovator in Alzheimer's Research
Introduction
David Gimbel is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of Alzheimer's research through his innovative work. His research focuses on the mechanisms of memory retention and the treatment of neurodegenerative diseases.
Latest Patents
David Gimbel holds a patent titled "Prion protein as a receptor for amyloid-β oligomers." This invention provides methods for inhibiting the suppression of long-term potentiation, improving acute memory retention, and enhancing spatial memory performance. It also offers potential treatments for Alzheimer's disease through the administration of a PrPc antagonist or combinations thereof. Additionally, the patent includes pharmaceutical kits and methods for identifying molecules that could function as PrP antagonists.
Career Highlights
David Gimbel is affiliated with Yale University, where he conducts his research. His work has garnered attention for its potential impact on understanding and treating Alzheimer's disease. He has been recognized for his innovative approach to addressing complex neurological issues.
Collaborations
David Gimbel has collaborated with esteemed colleagues such as Stephen M. Strittmatter and Juha Lauren. These collaborations have furthered the research in the field and contributed to the development of new therapeutic strategies.
Conclusion
David Gimbel's contributions to Alzheimer's research through his patent and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in understanding and treating neurodegenerative diseases.